New trial aims to protect Moms' hearts after preeclampsia

NCT ID NCT07199283

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 4 times

Summary

This trial tests a 9-month program for women who had preeclampsia during their first pregnancy. The program includes online screening, group meetings, and a smartphone app to help monitor blood pressure and weight. Researchers want to see if it improves heart health and promotes weight loss compared to standard care. 356 women are being recruited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bundle intervention (online screening, group meetings, self-monitoring app, lifestyle modification, health education)
What this could lead to
If it works, this could provide an effective program to help women lower their blood pressure and manage weight after preeclampsia, reducing future heart disease risk.
What could go wrong
This is a relatively small trial testing a behavioral intervention, not a drug. Results may vary, and long-term benefits are uncertain. The intervention requires active participation, which may limit its success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karolinska Institutet

    RECRUITING

    Stockholm, Stockholm County, 17177, Sweden

  • Karolinska University Hospital

    RECRUITING

    Stockholm, Stockholm County, 17176, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.